At the conclusion of this presentation the participant should be able to: 
1. Understand the evolution of targeted therapies for cancer treatment
2. Appreciate the role of genomic characterization of tumors in improving prognosis and treatment of cancer patients
3. Understand the potential of disrupting tumor-stroma intersections in evolving new approaches to pancreas cancer treatment.
Presentation: 54:0